Abstract
Improvement in heart failure therapy and perioperative management (technology and hemodynamic monitoring system) has led to an increasing number of cardiac patients eligible for anesthesia and surgery.
Patients who underwent previous surgical correction of VHD (valvular heart disease) and have a prosthetic (biological or mechanical) valve can undergo noncardiac surgery without additional risk, provided that there is no evidence of valve or ventricular dysfunction (tested with echocardiographic evaluation). They clearly need a modification of anticoagulant regimen in the perioperative period. Antibiotic prophylaxis is recommended in all patients at intermediate or high risk of infective endocarditis in the field of noncardiac surgery.
Patients with coronary stents need an accurate evaluation and management of antiplatelet therapy to avoid stent thrombosis.
In this chapter we will discuss the physiopathology of the most frequent heart diseases, excluding the rarer or congenital ones.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akhtar S, Silverman D. Assessment and management of patients with ischemic heart disease. Crit Care Med. 2004;32(4 Suppl):S126–36.
Chassot P-G, Delabays A, Spahn DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Br J Anaesth. 2002;89:747–59.
Karthikeyan G, Bhargava B. Managing patients undergoing non-cardiac surgery. Heart. 2006;92:17–20.
Kristensen SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–431.
Lee TH, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.
Konstadt S. Anesthesia for non-cardiac surgery in the patient with cardiac disease. Can J Anesth. 2005;52(Suppl. 1):R7.
Stoelting RK, Dierdorf SF. Anesthesia and co-existing disease. 4th ed. New York, NY: Churchill Livingstone; 2002. p. 105–16.
ACC/AHA. Guidelines for the management of patients with valvular heart disease. JACC. 2006;48:1–148.
Supino PG, Borer JS, Preibisz J, Bornstein A. The epidemiology of valvular heart disease: growing public health problem. Heart Fail Clin. 2006;2:379–93.
Kertai MD, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med. 2004;116:8–13.
Mochizuki Y, Pandian NG. Role of echocardiography in the diagnosis and treatment of patients with aortic stenosis. Curr Opin Cardiol. 2003;18:327–33.
Mittnacht AJ, Fanshawe M, Konstadt S. Anesthetic considerations in the patient with valvular heart disease for non cardiac surgery. Semin Cardiothorac Vasc Anesth. 2008;12(1):33–59.
Christ M, Sharkova Y, Gelener G, Maisch B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest. 2005;128:2944–53.
Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005;112:125–34.
Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ, American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802.
Messika-Zeitoun D, Lung B, Brochet E, Himbert D, Serfaty JM, Laissy JP, Vahanian A. Evaluation of mitral stenosis in 2008. Arch Cardiovasc Dis. 2008;101:653–63.
Klein AJ, Carroll JD. Left ventricular dysfunction and mitral stenosis. Heart Fail Clin. 2006;2:443–52.
Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol. 2008;52:319–26.
Ramakrishna G, Sprung J, Ravi BS, et al. Impact of pulmonary hypertension on the outcomes of noncardiac surgery predictors of perioperative morbidity and mortality. J Am Coll Cardiol. 2005;45:1691–9.
Behnia R, Molteni A, Igic R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Des. 2003;9:763–76.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Frasacco, G., Tritapepe, L. (2019). Cardiac Patients and Noncardiac Surgery: Pathophysiological Basis for Clinical Management. In: Chiumello, D. (eds) Practical Trends in Anesthesia and Intensive Care 2018. Springer, Cham. https://doi.org/10.1007/978-3-319-94189-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-94189-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-94188-2
Online ISBN: 978-3-319-94189-9
eBook Packages: MedicineMedicine (R0)